title: MET and MYC cooperate in mammary tumorigenesis.
abstract: In human breast cancer, overexpression of the protooncogene MET is strongly associated with poor prognosis and high risk of metastasis. It stands out as a reliable prognostic indicator of survival and defines a set of tumors exclusive of those that express HER2 or hormone receptors. Studies have shown that overexpression of mutant forms of MET cause cancer in mice. However, MET mutations have not been found in human breast cancer, and the consequences of overexpression of normal MET are unknown. To investigate the role of MET and other putative oncogenes in breast cancer, we developed an experimental system that involves retroviral delivery of genes into primary mammary epithelial cells, followed by transplantation of the transduced cells into mammary fat pads. Using this approach, we found that overexpression of wild-type MET leads to the development of nonprogressive neoplasms. The lesions progressed to mammary adenocarcinoma when a second protooncogene, MYC, was overexpressed, indicating that MET and MYC cooperate in mammary tumorigenesis. Both the nonprogressive neoplasms and adenocarcinomas display characteristics consistent with transformation and expansion of mammary progenitor cells. The approach described here should provide a useful model with which to efficiently test effects of various genes on tumor development in the breast.
authors.affiliation: G. W. Hooper Research Foundation and Department of Microbiology and Immunology, University of California, San Francisco, CA 94143, USA. awelm@itsa.ucsf.edu
authors.forename: Alana L
authors.initials: AL
authors.lastname: Welm
authors.forename: Suwon
authors.initials: S
authors.lastname: Kim
authors.forename: Bryan E
authors.initials: BE
authors.lastname: Welm
authors.forename: J Michael
authors.initials: JM
authors.lastname: Bishop
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000818:Animals; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000378:metabolism / Q000637:transplantation; D005260:Female; D015870:Gene Expression; D016259:Genes, myc; D005822:Genetic Vectors; D006801:Humans; D007633:Keratins / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000166:cytology / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000209:etiology* / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics*; D011519:Proto-Oncogenes; D012190:Retroviridae / Q000235:genetics; D013234:Stem Cells / Q000378:metabolism / Q000473:pathology; D014161:Transduction, Genetic
chemical_list: D007633:Keratins; D019859:Proto-Oncogene Proteins c-met
references.citation: Microsc Res Tech. 2001 Jan 15;52(2):224-30
references.pmid: 11169869
references.citation: Int J Cancer. 1997 Jun 20;74(3):301-9
references.pmid: 9221809
references.citation: J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):421-9
references.pmid: 7626491
references.citation: Dev Biol. 2002 May 1;245(1):42-56
references.pmid: 11969254
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14417-22
references.pmid: 9826715
references.citation: Nat Med. 2001 Feb;7(2):235-9
references.pmid: 11175856
references.citation: Genes Dev. 2003 May 15;17(10):1253-70
references.pmid: 12756227
references.citation: Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25
references.pmid: 14685170
references.citation: FASEB J. 2002 Mar;16(3):283-92
references.pmid: 11874978
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15853-8
references.pmid: 14668450
references.citation: J Virol. 1996 Aug;70(8):5701-5
references.pmid: 8764092
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(23):9202-6
references.pmid: 2251265
references.citation: Mol Cell Biol. 2001 Sep;21(17):5857-68
references.pmid: 11486025
references.citation: Trends Endocrinol Metab. 2004 Jul;15(5):193-7
references.pmid: 15223047
references.citation: Immunity. 1999 Sep;11(3):281-8
references.pmid: 10514006
references.citation: Cancer. 1998 Apr 15;82(8):1513-20
references.pmid: 9554529
references.citation: Dev Biol. 1983 Jun;97(2):274-90
references.pmid: 6852366
references.citation: Cancer. 2003 Apr 15;97(8):1841-8
references.pmid: 12673709
references.citation: J Clin Invest. 1996 Jun 15;97(12):2872-7
references.pmid: 8675700
references.citation: Cell Growth Differ. 1990 Apr;1(4):161-70
references.pmid: 1707299
references.citation: J Cell Sci. 2001 Sep;114(Pt 17):3147-53
references.pmid: 11590241
references.citation: Oncogene. 2000 Feb 21;19(8):1092-6
references.pmid: 10713695
references.citation: Cancer Res. 2002 Apr 1;62(7):2064-71
references.pmid: 11929826
references.citation: Oncogene. 2003 Nov 20;22(52):8498-508
references.pmid: 14627990
references.citation: J Cell Biol. 2001 May 28;153(5):1023-34
references.pmid: 11381087
references.citation: Nucleic Acids Res. 1990 May 25;18(10):2977-85
references.pmid: 2349094
references.citation: Genes Chromosomes Cancer. 1998 Dec;23(4):307-16
references.pmid: 9824203
references.citation: Cell Prolif. 2003 Oct;36 Suppl 1:59-72
references.pmid: 14521516
references.citation: Endocr Relat Cancer. 2000 Sep;7(3):143-64
references.pmid: 11021963
references.citation: Oncogene. 2000 Feb 21;19(8):968-88
references.pmid: 10713680
references.citation: Lab Invest. 1998 Sep;78(9):1143-53
references.pmid: 9759658
references.citation: J Biomed Biotechnol. 2001;1(3):133-143
references.pmid: 12488607
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17198-203
references.pmid: 15557554
references.citation: Proc Natl Acad Sci U S A. 1968 Sep;61(1):53-60
references.pmid: 4301594
references.citation: Cancer. 1999 Dec 1;86(11):2259-65
references.pmid: 10590366
references.citation: Development. 1998 May;125(10):1921-30
references.pmid: 9550724
references.citation: Cell. 1984 Oct;38(3):627-37
references.pmid: 6488314
references.citation: Development. 2001 Aug;128(16):3117-31
references.pmid: 11688561